Post Traumatic Stress Disorder Clinical Trials 2022

Browse 111 Post Traumatic Stress Disorder Medical Studies Across 149 Cities

7 Phase 3 Trial · 268 Post Traumatic Stress Disorder Clinics

Reviewed by Michael Gill, B. Sc.
Phase-Based Progress Estimates

5-Week Baselinefor Moral Injury

Lexington, KY
All Sexes
Mental contamination-an internal experience of dirtiness evoked in the absence of physical contact with an external source-has been linked to the development and maintenance of posttraumatic stress disorder (PTSD) following exposure to sexual abuse or assault (Adams et al., 2014; Badour et al., 2013; Brake et al., 2017). Mental contamination has been associated with greater PTSD severity (Rachman et al., 2015) and higher elevations in specific PTSD symptom clusters (particularly those of intrusive re-experiencing, negative cognitions/mood, and arousal/reactivity; Brake et al., 2019; Fergus & Bardeen, 2016). Additionally, trauma-related mental contamination has been linked to a number of negative posttraumatic emotions such as shame, guilt, disgust, and anger (Fairbrother & Rachman, 2004; Radomsky & Elliott, 2009). Despite clear and consistent links between mental contamination and problematic posttraumatic outcomes following sexual trauma, there is a dearth of research investigating how existing or promising new interventions for PTSD impact mental contamination. Written Exposure Therapy (WET) is a five-session treatment for PTSD that was designed to be both brief and easy to administer (Sloan et al., 2012). According to Sloan and colleagues' (2012) protocol, sessions broadly involve 30-minute exposures in which the patient writes about the events of their trauma in detail, followed by 10 minutes of discussing the exposure with the therapist. This treatment protocol has minimal therapist involvement, no homework assignments, and shorter treatment sessions. Research shows that WET is efficacious among different samples (e.g., survivors of motor vehicle accidents and combat veterans), has low dropout rates, treatment satisfaction is high, and the gains seen by participants after completion are maintained at follow-up (Sloan et al., 2012, 2013, 2018; Thompson-Hollands et al., 2018, 2019). Given these factors, WET has the potential to be a useful intervention in reducing symptoms of PTSD among a sample of survivors of sexual trauma. Given its relevance to this trauma population, a test of this intervention for its impact on reducing trauma-related mental contamination is also needed. The current study will use Single Case Experimental Design to isolate and evaluate the effects of WET in reducing both PTSD symptoms and trauma-related mental contamination among individuals with PTSD resulting from sexual trauma. Aims: Explore whether participants demonstrate reductions in mental contamination and PTSD symptoms in response to 5 sessions of WET. Visual inspection analysis and statistical methods will be used to draw conclusions regarding the effects of the interventions on PTSD symptoms and mental contamination.
Has No Placebo
25 Post Traumatic Stress Disorder Clinical Trials Near Me
Decatur, GA
Lincoln, NE
Oak Brook, IL
Mount Pleasant, SC
More Trial Locations
An interactive map to display trial locations for Atlanta VA Medical and Rehab Center, Decatur, GA, Alivation Research, LLC, American Medical Research, Inc, Coastal Carolina Research Center, and 47 more locations.
Most Popular References for Post Traumatic Stress Disorder Clinical Trials
Top Hospitals for Post Traumatic Stress Disorder Clinical Trials
Top Treatments for Post Traumatic Stress Disorder Clinical Trials
Treatment Name
Active Post Traumatic Stress Disorder Clinical Trials
All Time Trials for Post Traumatic Stress Disorder
First Recorded Post Traumatic Stress Disorder Trial
Which phases are most popular for post traumatic stress disorder clinical trials?
Most Recent Post Traumatic Stress Disorder Clinical Trials
Senior Friendly Post Traumatic Stress Disorder Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Post Traumatic Stress Disorder
Mechanism of Action
Active Post Traumatic Stress Disorder Clinical Trials
NYU Langone Health

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 26th, 2021

Last Reviewed: August 29th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.